Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$113.7K
1 trades · 1 insiders
Net · 90d
$-113.7K
Insiders on file
30
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Podlesak Dennis | Director | 37 | $197.1K | $2.89M | 2026-10-29 |
| Metzger Michael A | President and COO | 113 | $0 | $15.40M | 2026-07-08 |
| Botwood Nicholas A.J. | Head of R&D, CMO | 10 | $105.9K | $1.18M | 2026-06-12 |
| Goldan Keith A. | Chief Financial Officer | 25 | $25.0K | $220.5K | 2026-06-01 |
| Rizo Aleksandra | Director | 3 | $0 | $0 | 2026-02-04 |
| Jarrett Jennifer | Director | 9 | $0 | $0 | 2026-02-04 |
| Huber Martin H. Jr. | Director | 7 | $45.0K | $0 | 2026-02-04 |
| Legault Pierre | Director | 34 | $0 | $2.55M | 2026-02-04 |
| Katkin Keith | Director | 37 | $91.1K | $877.2K | 2026-02-04 |
| Gallagher Neil | President, Head of R&D | 8 | $0 | $71.6K | 2025-02-10 |
| Meury William | Director | 17 | $0 | $1.70M | 2025-02-05 |
| Morrison Briggs | President, Head of R&D | 88 | $311.7K | $26.01M | 2024-02-07 |
| Ordentlich Peter | Chief Scientific Officer | 46 | $0 | $2.80M | 2023-02-15 |
| Madigan Catherine | Chief Medical Officer | 2 | $0 | $0 | 2023-02-02 |
| Nolte Alexander | Chief Accounting Officer | 4 | $0 | $16.1K | 2023-02-02 |
| Sabus Steve M | Chief Commercial Officer | 1 | $0 | $0 | 2022-12-05 |
| Meyers Michael L. | SVP, Chief Medical Officer | 18 | $14.2K | $0 | 2022-02-02 |
| Egros Fabrice | Director | 30 | $0 | $1.00M | 2022-02-02 |
| Karydas Daphne | Chief Financial Officer | 1 | $0 | $0 | 2021-02-03 |
| Shea Richard P | Director | 8 | $0 | $0 | 2020-02-12 |
| BIOTECHNOLOGY VALUE FUND L P | Other | 6 | $0 | $0 | 2018-06-18 |
| Chen Henry | Director | 5 | $0 | $0 | 2018-05-23 |
| EVNIN LUKE | Director, 10% Owner | 11 | $0 | $0 | 2018-05-23 |
| Sledge George W. Jr. | Director | 2 | $0 | $0 | 2017-05-17 |
| ROYSTON IVOR | Director | 9 | $1.80M | $0 | 2017-03-20 |
| Kamdar Kim P. | Director, 10% Owner | 1 | $0 | $0 | 2016-10-31 |
| Halak Brian K | 10% Owner | 3 | $0 | $0 | 2016-03-08 |
| DOVEY BRIAN H | 10% Owner | 6 | $0 | $0 | 2016-03-08 |
| GADICKE ANSBERT | 10% Owner | 6 | $0 | $0 | 2016-03-08 |
| BLAIR JAMES C | 10% Owner | 2 | $0 | $0 | 2016-03-08 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Podlesak Dennis | Director | M Exercise deriv | 2026-10-29 | 2026-10-30 | 8,000 | — | $0 | 0 | SEC↗ |
| Podlesak Dennis | Director | S Sale | 2026-10-29 | 2026-10-30 | 8,000 | $14.21 | $113.7K | 239,763 | SEC↗ |
| Podlesak Dennis | Director | M Exercise | 2026-10-29 | 2026-10-30 | 8,000 | $11.81 | $94.5K | 247,763 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise deriv | 2026-07-08 | 2026-07-09 | 32,375 | — | $0 | 0 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise | 2026-07-08 | 2026-07-09 | 32,375 | $6.38 | $206.6K | 517,218 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | S Sale | 2026-07-08 | 2026-07-09 | 32,375 | $24.24 | $784.8K | 484,843 | SEC↗ |
| Botwood Nicholas A.J. | Head of R&D, CMO | M Exercise deriv | 2026-06-12 | 2026-06-12 | 31,235 | — | $0 | 0 | SEC↗ |
| Botwood Nicholas A.J. | Head of R&D, CMO | S Sale | 2026-06-12 | 2026-06-12 | 31,235 | $18.14 | $566.6K | 60,885 | SEC↗ |
| Botwood Nicholas A.J. | Head of R&D, CMO | M Exercise | 2026-06-12 | 2026-06-12 | 31,235 | $13.82 | $431.7K | 92,120 | SEC↗ |
| Botwood Nicholas A.J. | Head of R&D, CMO | M Exercise deriv | 2026-06-11 | 2026-06-12 | 22,515 | — | $0 | 0 | SEC↗ |
| Botwood Nicholas A.J. | Head of R&D, CMO | S Sale | 2026-06-11 | 2026-06-12 | 34,280 | $18.00 | $617.0K | 60,885 | SEC↗ |
| Botwood Nicholas A.J. | Head of R&D, CMO | M Exercise | 2026-06-11 | 2026-06-12 | 22,515 | $13.82 | $311.2K | 95,165 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | S Sale | 2026-06-01 | 2026-06-02 | 6,847 | $18.99 | $130.0K | 484,843 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | S Sale | 2026-06-01 | 2026-06-02 | 1,177 | $18.99 | $22.4K | 139,252 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | S Sale | 2026-02-09 | 2026-02-10 | 3,410 | $21.03 | $71.7K | 140,429 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | S Sale | 2026-02-09 | 2026-02-10 | 17,159 | $21.03 | $360.9K | 491,690 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | S Sale | 2026-02-06 | 2026-02-06 | 2,082 | $20.62 | $42.9K | 143,839 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | S Sale | 2026-02-06 | 2026-02-06 | 7,412 | $20.62 | $152.8K | 508,849 | SEC↗ |
| Botwood Nicholas A.J. | Head of R&D, CMO | A Award deriv | 2026-02-04 | 2026-02-06 | 144,700 | $20.43 | $2.96M | 144,700 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | A Award deriv | 2026-02-04 | 2026-02-06 | 118,000 | $20.43 | $2.41M | 118,000 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | A Award deriv | 2026-02-04 | 2026-02-06 | 440,000 | $20.43 | $8.99M | 440,000 | SEC↗ |
| Legault Pierre | Director | A Award | 2026-02-04 | 2026-02-06 | 24,000 | — | $0 | 114,000 | SEC↗ |
| Katkin Keith | Director | A Award | 2026-02-04 | 2026-02-06 | 24,000 | — | $0 | 124,000 | SEC↗ |
| Rizo Aleksandra | Director | A Award | 2026-02-04 | 2026-02-06 | 24,000 | — | $0 | 49,000 | SEC↗ |
| Podlesak Dennis | Director | A Award | 2026-02-04 | 2026-02-06 | 48,000 | — | $0 | 239,763 | SEC↗ |
| Botwood Nicholas A.J. | Head of R&D, CMO | A Award | 2026-02-04 | 2026-02-06 | 24,000 | — | $0 | 59,165 | SEC↗ |
| Botwood Nicholas A.J. | Head of R&D, CMO | A Award | 2026-02-04 | 2026-02-06 | 36,000 | — | $0 | 95,165 | SEC↗ |
| Huber Martin H. Jr. | Director | A Award | 2026-02-04 | 2026-02-06 | 24,000 | — | $0 | 103,000 | SEC↗ |
| Jarrett Jennifer | Director | A Award | 2026-02-04 | 2026-02-06 | 24,000 | — | $0 | 114,000 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | A Award | 2026-02-04 | 2026-02-06 | 21,500 | — | $0 | 115,171 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | A Award | 2026-02-04 | 2026-02-06 | 30,750 | — | $0 | 145,921 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | A Award | 2026-02-04 | 2026-02-06 | 144,600 | — | $0 | 516,261 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | A Award | 2026-02-04 | 2026-02-06 | 73,000 | — | $0 | 371,661 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | J Other | 2026-01-30 | 2026-02-06 | 1,219 | $8.48 | $10.3K | 93,671 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | G Gift | 2025-12-01 | 2025-12-01 | 1,224 | — | $0 | 92,452 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise deriv | 2025-09-08 | 2025-09-08 | 157,307 | — | $0 | 0 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise | 2025-09-08 | 2025-09-08 | 157,307 | $10.90 | $1.71M | 455,968 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | S Sale | 2025-09-08 | 2025-09-08 | 157,307 | $16.41 | $2.58M | 298,661 | SEC↗ |
| Podlesak Dennis | Director | M Exercise deriv | 2025-08-18 | 2025-08-18 | 19,200 | — | $0 | 0 | SEC↗ |
| Podlesak Dennis | Director | M Exercise | 2025-08-18 | 2025-08-18 | 19,200 | $7.20 | $138.2K | 210,963 | SEC↗ |
| Podlesak Dennis | Director | S Sale | 2025-08-18 | 2025-08-18 | 19,200 | $15.84 | $304.1K | 191,763 | SEC↗ |
| Podlesak Dennis | Director | M Exercise deriv | 2025-08-15 | 2025-08-18 | 4,800 | — | $0 | 0 | SEC↗ |
| Podlesak Dennis | Director | M Exercise deriv | 2025-08-15 | 2025-08-18 | 14,400 | — | $0 | 0 | SEC↗ |
| Podlesak Dennis | Director | M Exercise | 2025-08-15 | 2025-08-18 | 19,200 | $7.20 | $138.2K | 210,963 | SEC↗ |
| Podlesak Dennis | Director | S Sale | 2025-08-15 | 2025-08-18 | 19,200 | $15.54 | $298.4K | 191,763 | SEC↗ |
| Podlesak Dennis | Director | M Exercise deriv | 2025-08-14 | 2025-08-18 | 19,200 | — | $0 | 0 | SEC↗ |
| Podlesak Dennis | Director | M Exercise | 2025-08-14 | 2025-08-18 | 19,200 | $7.20 | $138.2K | 210,963 | SEC↗ |
| Podlesak Dennis | Director | S Sale | 2025-08-14 | 2025-08-18 | 19,200 | $14.19 | $272.4K | 191,763 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | J Other | 2025-07-31 | 2025-08-07 | 1,226 | $8.43 | $10.3K | 93,676 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | S Sale | 2025-07-16 | 2025-07-18 | 7,534 | $9.29 | $70.0K | 298,661 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | S Sale | 2025-07-16 | 2025-07-18 | 1,296 | $9.29 | $12.0K | 92,450 | SEC↗ |
| Katkin Keith | Director | P Buy | 2025-05-19 | 2025-05-19 | 10,000 | $9.11 | $91.1K | 100,000 | SEC↗ |
| Huber Martin H. Jr. | Director | P Buy | 2025-05-19 | 2025-05-19 | 5,000 | $8.99 | $45.0K | 79,000 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | P Buy | 2025-05-19 | 2025-05-19 | 3,000 | — | $0 | 93,746 | SEC↗ |
| Botwood Nicholas A.J. | Head of R&D, CMO | P Buy | 2025-05-16 | 2025-05-19 | 11,765 | $9.00 | $105.9K | 35,165 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise deriv | 2025-03-14 | 2025-03-17 | 6,074 | — | $0 | 0 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise | 2025-03-14 | 2025-03-17 | 6,074 | $7.20 | $43.7K | 306,195 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise deriv | 2025-03-04 | 2025-03-06 | 7,814 | — | $0 | 0 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise | 2025-03-04 | 2025-03-06 | 7,814 | $7.20 | $56.3K | 307,935 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | S Sale | 2025-03-04 | 2025-03-06 | 7,814 | $15.05 | $117.6K | 300,121 | SEC↗ |
| Gallagher Neil | President, Head of R&D | S Sale | 2025-02-10 | 2025-02-12 | 4,618 | $15.50 | $71.6K | 85,095 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | S Sale | 2025-02-10 | 2025-02-12 | 13,288 | $15.50 | $206.0K | 300,121 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | S Sale | 2025-02-10 | 2025-02-12 | 3,777 | $15.50 | $58.5K | 90,746 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | A Award deriv | 2025-02-05 | 2025-02-07 | 364,000 | $14.65 | $5.33M | 364,000 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | A Award deriv | 2025-02-05 | 2025-02-07 | 110,500 | $14.65 | $1.62M | 110,500 | SEC↗ |
| Gallagher Neil | President, Head of R&D | A Award deriv | 2025-02-05 | 2025-02-07 | 110,500 | $14.65 | $1.62M | 110,500 | SEC↗ |
| Legault Pierre | Director | A Award | 2025-02-05 | 2025-02-07 | 25,000 | — | $0 | 90,000 | SEC↗ |
| Huber Martin H. Jr. | Director | A Award | 2025-02-05 | 2025-02-07 | 25,000 | — | $0 | 74,000 | SEC↗ |
| Jarrett Jennifer | Director | A Award | 2025-02-05 | 2025-02-07 | 25,000 | — | $0 | 90,000 | SEC↗ |
| Katkin Keith | Director | A Award | 2025-02-05 | 2025-02-07 | 25,000 | — | $0 | 90,000 | SEC↗ |
| Meury William | Director | A Award | 2025-02-05 | 2025-02-07 | 25,000 | — | $0 | 90,000 | SEC↗ |
| Rizo Aleksandra | Director | A Award | 2025-02-05 | 2025-02-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Podlesak Dennis | Director | A Award | 2025-02-05 | 2025-02-07 | 50,000 | — | $0 | 191,763 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | A Award | 2025-02-05 | 2025-02-07 | 60,500 | — | $0 | 224,409 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | A Award | 2025-02-05 | 2025-02-07 | 89,000 | — | $0 | 313,409 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | A Award | 2025-02-05 | 2025-02-07 | 23,400 | — | $0 | 94,523 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | A Award | 2025-02-05 | 2025-02-07 | 18,500 | — | $0 | 71,123 | SEC↗ |
| Gallagher Neil | President, Head of R&D | A Award | 2025-02-05 | 2025-02-07 | 18,500 | — | $0 | 66,313 | SEC↗ |
| Gallagher Neil | President, Head of R&D | A Award | 2025-02-05 | 2025-02-07 | 23,400 | — | $0 | 89,713 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | P Buy | 2024-06-14 | 2024-06-17 | 1,250 | $20.03 | $25.0K | 52,623 | SEC↗ |
| Rizo Aleksandra | Director | A Award deriv | 2024-05-15 | 2024-05-16 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Gallagher Neil | President, Head of R&D | A Award deriv | 2024-02-07 | 2024-02-09 | 69,375 | $22.28 | $1.55M | 69,375 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | A Award deriv | 2024-02-07 | 2024-02-09 | 70,000 | $22.28 | $1.56M | 70,000 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | A Award deriv | 2024-02-07 | 2024-02-09 | 214,500 | $22.28 | $4.78M | 214,500 | SEC↗ |
| Legault Pierre | Director | A Award | 2024-02-07 | 2024-02-09 | 17,000 | — | $0 | 65,000 | SEC↗ |
| Podlesak Dennis | Director | A Award | 2024-02-07 | 2024-02-09 | 34,000 | — | $0 | 141,763 | SEC↗ |
| Morrison Briggs | Director | A Award | 2024-02-07 | 2024-02-09 | 17,000 | — | $0 | 34,836 | SEC↗ |
| Meury William | Director | A Award | 2024-02-07 | 2024-02-09 | 17,000 | — | $0 | 65,000 | SEC↗ |
| Katkin Keith | Director | A Award | 2024-02-07 | 2024-02-09 | 17,000 | — | $0 | 65,000 | SEC↗ |
| Jarrett Jennifer | Director | A Award | 2024-02-07 | 2024-02-09 | 17,000 | — | $0 | 65,000 | SEC↗ |
| Huber Martin H. Jr. | Director | A Award | 2024-02-07 | 2024-02-09 | 17,000 | — | $0 | 49,000 | SEC↗ |
| Gallagher Neil | President, Head of R&D | A Award | 2024-02-07 | 2024-02-09 | 13,125 | — | $0 | 47,813 | SEC↗ |
| Gallagher Neil | President, Head of R&D | A Award | 2024-02-07 | 2024-02-09 | 34,688 | — | $0 | 34,688 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | A Award | 2024-02-07 | 2024-02-09 | 35,000 | — | $0 | 39,673 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | A Award | 2024-02-07 | 2024-02-09 | 11,700 | — | $0 | 51,373 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | A Award | 2024-02-07 | 2024-02-09 | 39,000 | — | $0 | 163,909 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | A Award | 2024-02-07 | 2024-02-09 | 107,250 | — | $0 | 124,909 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | J Other | 2024-01-31 | 2024-02-09 | 1,183 | $17.42 | $20.6K | 4,673 | SEC↗ |
| Morrison Briggs | Director | M Exercise deriv | 2023-08-09 | 2023-08-10 | 52,855 | — | $0 | 0 | SEC↗ |
| Morrison Briggs | Director | M Exercise | 2023-08-09 | 2023-08-10 | 52,855 | $8.77 | $463.5K | 70,691 | SEC↗ |
| Morrison Briggs | Director | S Sale | 2023-08-09 | 2023-08-10 | 52,855 | $18.27 | $965.7K | 17,836 | SEC↗ |
| Meury William | Director | M Exercise deriv | 2023-08-02 | 2023-08-03 | 24,000 | — | $0 | 0 | SEC↗ |
| Meury William | Director | M Exercise deriv | 2023-08-02 | 2023-08-03 | 35,000 | — | $0 | 0 | SEC↗ |
| Meury William | Director | M Exercise deriv | 2023-08-02 | 2023-08-03 | 24,000 | — | $0 | 0 | SEC↗ |
| Meury William | Director | S Sale | 2023-08-02 | 2023-08-03 | 35,000 | $20.46 | $716.1K | 48,000 | SEC↗ |
| Meury William | Director | M Exercise | 2023-08-02 | 2023-08-03 | 24,000 | $7.88 | $189.1K | 72,000 | SEC↗ |
| Meury William | Director | S Sale | 2023-08-02 | 2023-08-03 | 24,000 | $20.46 | $491.0K | 48,000 | SEC↗ |
| Meury William | Director | M Exercise | 2023-08-02 | 2023-08-03 | 24,000 | $9.47 | $227.3K | 72,000 | SEC↗ |
| Meury William | Director | M Exercise | 2023-08-02 | 2023-08-03 | 35,000 | $7.11 | $248.8K | 83,000 | SEC↗ |
| Meury William | Director | S Sale | 2023-08-02 | 2023-08-03 | 24,000 | $20.45 | $490.8K | 48,000 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | J Other | 2023-07-31 | 2024-02-09 | 862 | $18.12 | $15.6K | 3,490 | SEC↗ |
| Morrison Briggs | Director | M Exercise deriv | 2023-07-10 | 2023-07-11 | 52,855 | — | $0 | 0 | SEC↗ |
| Morrison Briggs | Director | M Exercise | 2023-07-10 | 2023-07-11 | 52,855 | $8.77 | $463.5K | 70,691 | SEC↗ |
| Morrison Briggs | Director | S Sale | 2023-07-10 | 2023-07-11 | 52,855 | $20.40 | $1.08M | 17,836 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | S Sale | 2023-06-13 | 2023-06-14 | 577 | $22.31 | $12.9K | 2,628 | SEC↗ |
| Morrison Briggs | Director | M Exercise deriv | 2023-06-09 | 2023-06-09 | 28,273 | — | $0 | 0 | SEC↗ |
| Morrison Briggs | Director | M Exercise deriv | 2023-06-09 | 2023-06-09 | 24,582 | — | $0 | 0 | SEC↗ |
| Morrison Briggs | Director | M Exercise | 2023-06-09 | 2023-06-09 | 28,273 | $8.77 | $248.0K | 70,691 | SEC↗ |
| Morrison Briggs | Director | M Exercise | 2023-06-09 | 2023-06-09 | 24,582 | $6.38 | $156.8K | 42,418 | SEC↗ |
| Morrison Briggs | Director | S Sale | 2023-06-09 | 2023-06-09 | 24,582 | $21.18 | $520.6K | 46,109 | SEC↗ |
| Morrison Briggs | Director | S Sale | 2023-06-09 | 2023-06-09 | 28,273 | $21.18 | $598.8K | 17,836 | SEC↗ |
| Morrison Briggs | Director | M Exercise deriv | 2023-05-09 | 2023-05-10 | 52,855 | — | $0 | 0 | SEC↗ |
| Morrison Briggs | Director | S Sale | 2023-05-09 | 2023-05-10 | 52,855 | $21.41 | $1.13M | 17,836 | SEC↗ |
| Morrison Briggs | Director | M Exercise | 2023-05-09 | 2023-05-10 | 52,855 | $6.38 | $337.2K | 70,691 | SEC↗ |
| Gallagher Neil | President, Head of R&D | A Award deriv | 2023-04-10 | 2023-04-12 | 250,000 | $19.35 | $4.84M | 250,000 | SEC↗ |
| Morrison Briggs | Director | M Exercise deriv | 2023-04-10 | 2023-04-12 | 52,855 | — | $0 | 0 | SEC↗ |
| Morrison Briggs | Director | S Sale | 2023-04-10 | 2023-04-12 | 52,855 | $19.53 | $1.03M | 17,836 | SEC↗ |
| Morrison Briggs | Director | M Exercise | 2023-04-10 | 2023-04-12 | 52,855 | $6.38 | $337.2K | 70,691 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise deriv | 2023-03-13 | 2023-03-14 | 52,854 | — | $0 | 0 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise | 2023-03-13 | 2023-03-14 | 52,854 | $6.38 | $337.2K | 70,690 | SEC↗ |
| Morrison Briggs | President, Head of R&D | S Sale | 2023-03-13 | 2023-03-14 | 52,854 | $22.53 | $1.19M | 17,836 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | M Exercise deriv | 2023-02-15 | 2023-02-17 | 17,428 | $25.84 | $450.3K | 0 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | M Exercise deriv | 2023-02-15 | 2023-02-17 | 7,572 | $25.84 | $195.7K | 0 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | S Sale | 2023-02-15 | 2023-02-17 | 17,428 | $25.84 | $450.3K | 0 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | S Sale | 2023-02-15 | 2023-02-17 | 7,572 | $25.84 | $195.7K | 0 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | M Exercise | 2023-02-15 | 2023-02-17 | 17,428 | $7.20 | $125.5K | 17,428 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | M Exercise | 2023-02-15 | 2023-02-17 | 7,572 | $6.38 | $48.3K | 7,572 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise deriv | 2023-02-06 | 2023-02-08 | 52,854 | — | $0 | 0 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise deriv | 2023-02-06 | 2023-02-08 | 5,959 | $27.64 | $164.7K | 0 | SEC↗ |
| Morrison Briggs | President, Head of R&D | S Sale | 2023-02-06 | 2023-02-08 | 52,854 | $26.83 | $1.42M | 17,836 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise | 2023-02-06 | 2023-02-08 | 52,854 | $6.38 | $337.2K | 70,690 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise | 2023-02-06 | 2023-02-08 | 5,959 | $6.38 | $38.0K | 23,618 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | S Sale | 2023-02-06 | 2023-02-08 | 5,959 | $27.64 | $164.7K | 17,659 | SEC↗ |
| Nolte Alexander | Chief Accounting Officer | A Award deriv | 2023-02-02 | 2023-02-03 | 17,000 | $28.55 | $485.4K | 17,000 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | A Award deriv | 2023-02-02 | 2023-02-03 | 90,000 | $28.55 | $2.57M | 90,000 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | A Award deriv | 2023-02-02 | 2023-02-03 | 110,000 | $28.55 | $3.14M | 110,000 | SEC↗ |
| Madigan Catherine | Chief Medical Officer | A Award deriv | 2023-02-02 | 2023-02-03 | 110,000 | $28.55 | $3.14M | 110,000 | SEC↗ |
| Morrison Briggs | President, Head of R&D | A Award deriv | 2023-02-02 | 2023-02-03 | 32,000 | $28.55 | $913.6K | 32,000 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | A Award deriv | 2023-02-02 | 2023-02-03 | 410,000 | $28.55 | $11.71M | 410,000 | SEC↗ |
| Jarrett Jennifer | Director | A Award | 2023-02-02 | 2023-02-03 | 16,000 | — | $0 | 48,000 | SEC↗ |
| Katkin Keith | Director | A Award | 2023-02-02 | 2023-02-03 | 16,000 | — | $0 | 48,000 | SEC↗ |
| Legault Pierre | Director | A Award | 2023-02-02 | 2023-02-03 | 16,000 | — | $0 | 48,000 | SEC↗ |
| Meury William | Director | A Award | 2023-02-02 | 2023-02-03 | 16,000 | — | $0 | 48,000 | SEC↗ |
| Huber Martin H. Jr. | Director | A Award | 2023-02-02 | 2023-02-03 | 16,000 | — | $0 | 32,000 | SEC↗ |
| Podlesak Dennis | Director | A Award | 2023-02-02 | 2023-02-03 | 32,000 | — | $0 | 107,763 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | S Sale | 2023-02-01 | 2023-02-03 | 69 | $28.43 | $2.0K | 0 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | J Other | 2023-01-31 | 2023-02-03 | 69 | $17.32 | $1.2K | 69 | SEC↗ |
| Legault Pierre | Director | M Exercise deriv | 2023-01-13 | 2023-01-13 | 5,000 | — | $0 | 0 | SEC↗ |
| Legault Pierre | Director | M Exercise deriv | 2023-01-13 | 2023-01-13 | 10,000 | — | $0 | 0 | SEC↗ |
| Legault Pierre | Director | M Exercise | 2023-01-13 | 2023-01-13 | 5,000 | $13.58 | $67.9K | 37,000 | SEC↗ |
| Legault Pierre | Director | S Sale | 2023-01-13 | 2023-01-13 | 10,000 | $27.00 | $270.0K | 32,000 | SEC↗ |
| Legault Pierre | Director | M Exercise | 2023-01-13 | 2023-01-13 | 10,000 | $13.58 | $135.8K | 42,000 | SEC↗ |
| Legault Pierre | Director | S Sale | 2023-01-13 | 2023-01-13 | 5,000 | $27.00 | $135.0K | 32,000 | SEC↗ |
| Legault Pierre | Director | M Exercise deriv | 2023-01-12 | 2023-01-13 | 24,000 | — | $0 | 0 | SEC↗ |
| Legault Pierre | Director | M Exercise | 2023-01-12 | 2023-01-13 | 24,000 | $9.47 | $227.3K | 56,000 | SEC↗ |
| Legault Pierre | Director | S Sale | 2023-01-12 | 2023-01-13 | 24,000 | $26.74 | $641.8K | 32,000 | SEC↗ |
| Sabus Steve M | Chief Commercial Officer | A Award deriv | 2022-12-05 | 2022-12-05 | 220,000 | $25.44 | $5.60M | 220,000 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | M Exercise deriv | 2022-12-02 | 2022-12-02 | 17,200 | — | $0 | 0 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | S Sale | 2022-12-02 | 2022-12-02 | 17,200 | $25.05 | $430.9K | 265 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | M Exercise | 2022-12-02 | 2022-12-02 | 17,200 | $6.38 | $109.7K | 17,465 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | M Exercise deriv | 2022-12-01 | 2022-12-02 | 3,772 | — | $0 | 0 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | M Exercise deriv | 2022-12-01 | 2022-12-02 | 4,028 | — | $0 | 0 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | S Sale | 2022-12-01 | 2022-12-02 | 3,772 | $25.01 | $94.3K | 265 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | M Exercise | 2022-12-01 | 2022-12-02 | 3,772 | $6.35 | $24.0K | 4,037 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | S Sale | 2022-12-01 | 2022-12-02 | 4,028 | $25.01 | $100.7K | 265 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | M Exercise | 2022-12-01 | 2022-12-02 | 4,028 | $6.38 | $25.7K | 4,293 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise deriv | 2022-10-06 | 2022-10-07 | 16,231 | — | $0 | 0 | SEC↗ |
| Katkin Keith | Director | M Exercise deriv | 2022-10-06 | 2022-10-07 | 20,782 | — | $0 | 0 | SEC↗ |
| Katkin Keith | Director | M Exercise deriv | 2022-10-06 | 2022-10-07 | 9,117 | — | $0 | 0 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise | 2022-10-06 | 2022-10-07 | 16,231 | $8.77 | $142.3K | 33,890 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | S Sale | 2022-10-06 | 2022-10-07 | 16,231 | $25.29 | $410.5K | 17,659 | SEC↗ |
| Katkin Keith | Director | M Exercise | 2022-10-06 | 2022-10-07 | 20,782 | $7.88 | $163.8K | 52,782 | SEC↗ |
| Katkin Keith | Director | S Sale | 2022-10-06 | 2022-10-07 | 9,117 | $25.90 | $236.1K | 32,000 | SEC↗ |
| Katkin Keith | Director | S Sale | 2022-10-06 | 2022-10-07 | 20,782 | $25.90 | $538.3K | 32,000 | SEC↗ |
| Katkin Keith | Director | M Exercise | 2022-10-06 | 2022-10-07 | 9,117 | $8.93 | $81.4K | 41,117 | SEC↗ |
| Katkin Keith | Director | M Exercise deriv | 2022-10-04 | 2022-10-04 | 223 | — | $0 | 0 | SEC↗ |
| Katkin Keith | Director | M Exercise deriv | 2022-10-04 | 2022-10-04 | 137 | — | $0 | 0 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise deriv | 2022-10-04 | 2022-10-04 | 1,280 | — | $0 | 0 | SEC↗ |
| Katkin Keith | Director | M Exercise | 2022-10-04 | 2022-10-04 | 137 | $7.88 | $1.1K | 32,137 | SEC↗ |
| Katkin Keith | Director | S Sale | 2022-10-04 | 2022-10-04 | 137 | $25.00 | $3.4K | 32,000 | SEC↗ |
| Katkin Keith | Director | M Exercise | 2022-10-04 | 2022-10-04 | 223 | $8.93 | $2.0K | 32,223 | SEC↗ |
| Katkin Keith | Director | S Sale | 2022-10-04 | 2022-10-04 | 223 | $25.00 | $5.6K | 32,000 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | S Sale | 2022-10-04 | 2022-10-04 | 1,280 | $25.02 | $32.0K | 17,659 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise | 2022-10-04 | 2022-10-04 | 1,280 | $8.77 | $11.2K | 18,939 | SEC↗ |
| Katkin Keith | Director | M Exercise deriv | 2022-10-03 | 2022-10-04 | 167 | — | $0 | 0 | SEC↗ |
| Katkin Keith | Director | M Exercise deriv | 2022-10-03 | 2022-10-04 | 13 | — | $0 | 0 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise deriv | 2022-10-03 | 2022-10-04 | 2,883 | — | $0 | 0 | SEC↗ |
| Katkin Keith | Director | M Exercise | 2022-10-03 | 2022-10-04 | 167 | $7.88 | $1.3K | 32,167 | SEC↗ |
| Katkin Keith | Director | S Sale | 2022-10-03 | 2022-10-04 | 167 | $25.00 | $4.2K | 32,000 | SEC↗ |
| Katkin Keith | Director | M Exercise | 2022-10-03 | 2022-10-04 | 13 | $8.93 | $116 | 32,013 | SEC↗ |
| Katkin Keith | Director | S Sale | 2022-10-03 | 2022-10-04 | 13 | $25.00 | $325 | 32,000 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise | 2022-10-03 | 2022-10-04 | 2,883 | $8.77 | $25.3K | 20,542 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | S Sale | 2022-10-03 | 2022-10-04 | 2,883 | $25.01 | $72.1K | 17,659 | SEC↗ |
| Katkin Keith | Director | M Exercise deriv | 2022-09-30 | 2022-10-04 | 647 | — | $0 | 0 | SEC↗ |
| Katkin Keith | Director | M Exercise deriv | 2022-09-30 | 2022-10-04 | 2,914 | — | $0 | 0 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise deriv | 2022-09-30 | 2022-10-04 | 29,606 | — | $0 | 0 | SEC↗ |
| Katkin Keith | Director | S Sale | 2022-09-30 | 2022-10-04 | 2,914 | $25.07 | $73.1K | 32,000 | SEC↗ |
| Katkin Keith | Director | M Exercise | 2022-09-30 | 2022-10-04 | 647 | $8.93 | $5.8K | 32,647 | SEC↗ |
| Katkin Keith | Director | S Sale | 2022-09-30 | 2022-10-04 | 647 | $25.07 | $16.2K | 32,000 | SEC↗ |
| Katkin Keith | Director | M Exercise | 2022-09-30 | 2022-10-04 | 2,914 | $7.88 | $23.0K | 34,914 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise | 2022-09-30 | 2022-10-04 | 29,606 | $8.77 | $259.6K | 47,265 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | S Sale | 2022-09-30 | 2022-10-04 | 29,606 | $25.02 | $740.7K | 17,659 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise deriv | 2022-09-20 | 2022-09-21 | 59,649 | — | $0 | 0 | SEC↗ |
| Morrison Briggs | President, Head of R&D | S Sale | 2022-09-20 | 2022-09-21 | 59,649 | $23.25 | $1.39M | 17,836 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise | 2022-09-20 | 2022-09-21 | 59,649 | $10.90 | $650.2K | 77,485 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise deriv | 2022-09-19 | 2022-09-21 | 114,339 | — | $0 | 0 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise | 2022-09-19 | 2022-09-21 | 114,339 | $10.90 | $1.25M | 132,175 | SEC↗ |
| Morrison Briggs | President, Head of R&D | S Sale | 2022-09-19 | 2022-09-21 | 114,339 | $23.03 | $2.63M | 17,836 | SEC↗ |
| Podlesak Dennis | Director | M Exercise deriv | 2022-09-16 | 2022-09-16 | 5,419 | — | $0 | 0 | SEC↗ |
| Podlesak Dennis | Director | M Exercise deriv | 2022-09-16 | 2022-09-16 | 6,556 | — | $0 | 0 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise deriv | 2022-09-16 | 2022-09-16 | 53,034 | — | $0 | 0 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise deriv | 2022-09-16 | 2022-09-16 | 71,966 | — | $0 | 0 | SEC↗ |
| Podlesak Dennis | Director | M Exercise | 2022-09-16 | 2022-09-16 | 5,419 | $6.32 | $34.2K | 81,182 | SEC↗ |
| Podlesak Dennis | Director | S Sale | 2022-09-16 | 2022-09-16 | 6,556 | $23.43 | $153.6K | 75,763 | SEC↗ |
| Podlesak Dennis | Director | M Exercise | 2022-09-16 | 2022-09-16 | 6,556 | $6.35 | $41.6K | 82,319 | SEC↗ |
| Podlesak Dennis | Director | S Sale | 2022-09-16 | 2022-09-16 | 5,419 | $23.43 | $127.0K | 75,763 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise | 2022-09-16 | 2022-09-16 | 71,966 | $7.20 | $518.2K | 89,802 | SEC↗ |
| Morrison Briggs | President, Head of R&D | S Sale | 2022-09-16 | 2022-09-16 | 71,966 | $23.22 | $1.67M | 17,836 | SEC↗ |
| Morrison Briggs | President, Head of R&D | S Sale | 2022-09-16 | 2022-09-16 | 53,034 | $23.22 | $1.23M | 17,836 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise | 2022-09-16 | 2022-09-16 | 53,034 | $10.90 | $578.1K | 70,870 | SEC↗ |
| Podlesak Dennis | Director | M Exercise deriv | 2022-09-15 | 2022-09-16 | 66,840 | — | $0 | 0 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise deriv | 2022-09-15 | 2022-09-16 | 66,775 | — | $0 | 0 | SEC↗ |
| Podlesak Dennis | Director | S Sale | 2022-09-15 | 2022-09-16 | 66,840 | $24.20 | $1.62M | 75,763 | SEC↗ |
| Podlesak Dennis | Director | M Exercise | 2022-09-15 | 2022-09-16 | 66,840 | $6.32 | $422.4K | 142,603 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise | 2022-09-15 | 2022-09-16 | 66,775 | $7.20 | $480.8K | 84,611 | SEC↗ |
| Morrison Briggs | President, Head of R&D | S Sale | 2022-09-15 | 2022-09-16 | 66,775 | $24.20 | $1.62M | 17,836 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise deriv | 2022-09-14 | 2022-09-16 | 87,645 | — | $0 | 0 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise | 2022-09-14 | 2022-09-16 | 87,645 | $7.20 | $631.0K | 105,481 | SEC↗ |
| Morrison Briggs | President, Head of R&D | S Sale | 2022-09-14 | 2022-09-16 | 87,645 | $23.80 | $2.09M | 17,836 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | M Exercise deriv | 2022-08-24 | 2022-08-26 | 2,154 | — | $0 | 0 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | M Exercise deriv | 2022-08-24 | 2022-08-26 | 22,846 | — | $0 | 0 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | S Sale | 2022-08-24 | 2022-08-26 | 22,846 | $25.04 | $572.1K | 265 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | M Exercise | 2022-08-24 | 2022-08-26 | 22,846 | $6.32 | $144.4K | 23,111 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | S Sale | 2022-08-24 | 2022-08-26 | 2,154 | $25.04 | $53.9K | 265 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | M Exercise | 2022-08-24 | 2022-08-26 | 2,154 | $6.35 | $13.7K | 2,419 | SEC↗ |
| Legault Pierre | Director | M Exercise deriv | 2022-08-05 | 2022-08-09 | 14,000 | — | $0 | 0 | SEC↗ |
| Legault Pierre | Director | M Exercise deriv | 2022-08-05 | 2022-08-09 | 10,000 | — | $0 | 0 | SEC↗ |
| Legault Pierre | Director | S Sale | 2022-08-05 | 2022-08-09 | 14,000 | $23.02 | $322.3K | 32,000 | SEC↗ |
| Legault Pierre | Director | M Exercise | 2022-08-05 | 2022-08-09 | 14,000 | $8.93 | $125.0K | 46,000 | SEC↗ |
| Legault Pierre | Director | S Sale | 2022-08-05 | 2022-08-09 | 10,000 | $23.02 | $230.2K | 32,000 | SEC↗ |
| Legault Pierre | Director | M Exercise | 2022-08-05 | 2022-08-09 | 10,000 | $9.63 | $96.3K | 42,000 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | J Other | 2022-07-29 | 2022-08-26 | 265 | $14.12 | $3.7K | 265 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise deriv | 2022-07-25 | 2022-07-27 | 19,764 | — | $0 | 0 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise deriv | 2022-07-25 | 2022-07-27 | 11,838 | — | $0 | 0 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise | 2022-07-25 | 2022-07-27 | 11,838 | $6.38 | $75.5K | 29,497 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise | 2022-07-25 | 2022-07-27 | 19,764 | $6.38 | $126.1K | 37,423 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | S Sale | 2022-07-25 | 2022-07-27 | 19,764 | $21.06 | $416.2K | 17,659 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | S Sale | 2022-07-25 | 2022-07-27 | 11,838 | $21.06 | $249.3K | 17,659 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise deriv | 2022-07-07 | 2022-07-08 | 100 | — | $0 | 0 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | S Sale | 2022-07-07 | 2022-07-08 | 100 | $21.00 | $2.1K | 17,659 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise | 2022-07-07 | 2022-07-08 | 100 | $6.38 | $638 | 17,759 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise deriv | 2022-07-06 | 2022-07-08 | 15,009 | — | $0 | 0 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | S Sale | 2022-07-06 | 2022-07-08 | 15,009 | $21.07 | $316.2K | 17,659 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | M Exercise | 2022-07-06 | 2022-07-08 | 15,009 | $6.38 | $95.8K | 32,668 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise deriv | 2022-07-01 | 2022-07-05 | 62,292 | — | $0 | 0 | SEC↗ |
| Morrison Briggs | President, Head of R&D | S Sale | 2022-07-01 | 2022-07-05 | 62,292 | $19.00 | $1.18M | 17,836 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise | 2022-07-01 | 2022-07-05 | 62,292 | $7.20 | $448.5K | 80,128 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | A Award deriv | 2022-06-13 | 2022-06-15 | 230,000 | $15.60 | $3.59M | 230,000 | SEC↗ |
| Goldan Keith A. | Chief Financial Officer | A Award | 2022-06-13 | 2022-06-15 | 3,205 | — | $0 | 3,205 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise deriv | 2022-04-04 | 2022-04-05 | 3,128 | — | $0 | 0 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise deriv | 2022-04-04 | 2022-04-13 | 3,128 | — | $0 | 0 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise | 2022-04-04 | 2022-04-05 | 3,128 | $10.90 | $34.1K | 20,964 | SEC↗ |
| Morrison Briggs | President, Head of R&D | S Sale | 2022-04-04 | 2022-04-05 | 3,128 | $18.29 | $57.2K | 17,836 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise | 2022-04-04 | 2022-04-13 | 3,128 | $7.20 | $22.5K | 20,964 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise deriv | 2022-04-01 | 2022-04-05 | 70,545 | — | $0 | 0 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise deriv | 2022-04-01 | 2022-04-13 | 70,545 | — | $0 | 0 | SEC↗ |
| Morrison Briggs | President, Head of R&D | S Sale | 2022-04-01 | 2022-04-05 | 6,000 | $17.44 | $104.6K | 42,336 | SEC↗ |
| Morrison Briggs | President, Head of R&D | S Sale | 2022-04-01 | 2022-04-05 | 24,500 | $17.44 | $427.3K | 17,836 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise | 2022-04-01 | 2022-04-05 | 70,545 | $10.90 | $768.9K | 88,381 | SEC↗ |
| Morrison Briggs | President, Head of R&D | S Sale | 2022-04-01 | 2022-04-05 | 70,545 | $17.46 | $1.23M | 17,836 | SEC↗ |
| Morrison Briggs | President, Head of R&D | M Exercise | 2022-04-01 | 2022-04-13 | 70,545 | $7.20 | $507.9K | 88,381 | SEC↗ |
| Madigan Catherine | Chief Medical Officer | A Award deriv | 2022-03-01 | 2022-03-03 | 180,000 | $16.06 | $2.89M | 180,000 | SEC↗ |
| Nolte Alexander | Chief Accounting Officer | A Award deriv | 2022-02-02 | 2022-02-03 | 30,000 | $15.79 | $473.7K | 30,000 | SEC↗ |
| Meyers Michael L. | SVP, Chief Medical Officer | A Award deriv | 2022-02-02 | 2022-02-03 | 17,350 | $15.79 | $274.0K | 17,350 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | A Award deriv | 2022-02-02 | 2022-02-03 | 80,000 | $15.79 | $1.26M | 80,000 | SEC↗ |
| Morrison Briggs | President, Head of R&D | A Award deriv | 2022-02-02 | 2022-02-03 | 160,000 | $15.79 | $2.53M | 160,000 | SEC↗ |
| Metzger Michael A | Chief Executive Officer | A Award deriv | 2022-02-02 | 2022-02-03 | 325,000 | $15.79 | $5.13M | 325,000 | SEC↗ |
| Huber Martin H. Jr. | Director | A Award | 2022-02-02 | 2022-02-03 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Meury William | Director | A Award | 2022-02-02 | 2022-02-03 | 16,000 | — | $0 | 32,000 | SEC↗ |
| Jarrett Jennifer | Director | A Award | 2022-02-02 | 2022-02-03 | 16,000 | — | $0 | 32,000 | SEC↗ |
| Egros Fabrice | Director | A Award | 2022-02-02 | 2022-02-03 | 16,000 | — | $0 | 32,000 | SEC↗ |
| Legault Pierre | Director | A Award | 2022-02-02 | 2022-02-03 | 16,000 | — | $0 | 32,000 | SEC↗ |
| Katkin Keith | Director | A Award | 2022-02-02 | 2022-02-03 | 16,000 | — | $0 | 32,000 | SEC↗ |
| Podlesak Dennis | Director | A Award | 2022-02-02 | 2022-02-03 | 32,000 | — | $0 | 75,763 | SEC↗ |
| Nolte Alexander | Chief Accounting Officer | S Sale | 2022-02-01 | 2022-02-03 | 968 | $16.65 | $16.1K | 0 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | S Sale | 2022-02-01 | 2022-02-03 | 1,412 | $16.65 | $23.5K | 0 | SEC↗ |
| Nolte Alexander | Chief Accounting Officer | J Other | 2022-01-31 | 2022-02-03 | 968 | $12.39 | $12.0K | 968 | SEC↗ |
| Meyers Michael L. | SVP, Chief Medical Officer | J Other | 2022-01-31 | 2022-02-03 | 1,714 | $12.39 | $21.2K | 23,280 | SEC↗ |
| Ordentlich Peter | Chief Scientific Officer | J Other | 2022-01-31 | 2022-02-03 | 1,412 | $12.39 | $17.5K | 1,412 | SEC↗ |
| Meyers Michael L. | SVP, Chief Medical Officer | M Exercise deriv | 2021-12-30 | 2022-01-03 | 5,900 | — | $0 | 0 | SEC↗ |